Cargando…

The Role of Osteoprotegerin and Its Ligands in Vascular Function

The superfamily of tumor necrosis factor (TNF) receptors includes osteoprotegerin (OPG) and its ligands, which are receptor activators of nuclear factor kappa-B ligand (RANKL) and TNF-related apoptosis-inducing ligand (TRAIL). The OPG/RANKL/RANK system plays an active role in pathological angiogenes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rochette, Luc, Meloux, Alexandre, Rigal, Eve, Zeller, Marianne, Cottin, Yves, Vergely, Catherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387017/ https://www.ncbi.nlm.nih.gov/pubmed/30736365 http://dx.doi.org/10.3390/ijms20030705

Ejemplares similares

Regenerative Capacity of Endogenous Factor: Growth Differentiation Factor 11; a New Approach of the Management of Age-Related Cardiovascular Events
por: Rochette, Luc, et al.
Publicado: (2018)

Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction
por: Cottin, Yves, et al.
Publicado: (2021)

Involvement of Oxidative Stress in Protective Cardiac Functions of Calprotectin
por: Rochette, Luc, et al.
Publicado: (2022)

Mitochondrial SLC25 Carriers: Novel Targets for Cancer Therapy
por: Rochette, Luc, et al.
Publicado: (2020)

Lipid Peroxidation and Iron Metabolism: Two Corner Stones in the Homeostasis Control of Ferroptosis
por: Rochette, Luc, et al.
Publicado: (2022)

Anti-Aging Effects of GDF11 on Skin
por: Rochette, Luc, et al.
Publicado: (2020)

GDF15 : A modulator of immunity and a predictive biomarker of cardiovascular events : A strategy in COVID-19
por: Rochette, Luc, et al.
Publicado: (2023)

Growth Differentiation Factor-8 (GDF8)/Myostatin Is a Predictor of Troponin I Peak and a Marker of Clinical Severity after Acute Myocardial Infarction
por: Meloux, Alexandre, et al.
Publicado: (2019)

Antitumor Activity of Protons and Molecular Hydrogen: Underlying Mechanisms
por: Rochette, Luc, et al.
Publicado: (2021)

GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism
por: Rochette, Luc, et al.
Publicado: (2021)

GDF15 and Cardiac Cells: Current Concepts and New Insights
por: Rochette, Luc, et al.
Publicado: (2021)

Programming of Cardiovascular Dysfunction by Postnatal Overfeeding in Rodents
por: Josse, Marie, et al.
Publicado: (2020)

The Crosstalk of Adipose-Derived Stem Cells (ADSC), Oxidative Stress, and Inflammation in Protective and Adaptive Responses
por: Rochette, Luc, et al.
Publicado: (2020)

Antitumoral Activity of Molecular Hydrogen and Proton in the Treatment of Glioblastoma: An Atypical Pharmacology?
por: Rochette, Luc, et al.
Publicado: (2023)

Vascular density with optical coherence tomography angiography and systemic biomarkers in low and high cardiovascular risk patients
por: Hannappe, Marc-Antoine, et al.
Publicado: (2020)

Atrial Fibrillation Is Associated with a Marker of Endothelial Function and Oxidative Stress in Patients with Acute Myocardial Infarction
por: Stamboul, Karim, et al.
Publicado: (2015)

Increased Symmetric Dimethylarginine Level Is Associated with Worse Hospital Outcomes through Altered Left Ventricular Ejection Fraction in Patients with Acute Myocardial Infarction
por: Lorin, Julie, et al.
Publicado: (2017)

Postnatal Overfeeding Causes Early Shifts in Gene Expression in the Heart and Long-Term Alterations in Cardiometabolic and Oxidative Parameters
por: Habbout, Ahmed, et al.
Publicado: (2013)

Relation between high levels of myeloperoxidase in the culprit artery and microvascular obstruction, infarct size and reverse remodeling in ST-elevation myocardial infarction
por: Stamboul, Karim, et al.
Publicado: (2017)

High Levels of Asymmetric Dimethylarginine Are Strongly Associated with Low HDL in Patients with Acute Myocardial Infarction
por: Lorin, Julie, et al.
Publicado: (2013)

Short-term moderate diet restriction in adulthood can reverse oxidative, cardiovascular and metabolic alterations induced by postnatal overfeeding in mice
por: Li, Na, et al.
Publicado: (2016)

Stress: Eight Decades after Its Definition by Hans Selye: “Stress Is the Spice of Life”
por: Rochette, Luc, et al.
Publicado: (2023)

Forgotten Radicals in Biology
por: Luc, Rochette, et al.
Publicado: (2008)

Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013)

Growth Differentiation Factor-15 (GDF-15) Levels Are Associated with Cardiac and Renal Injury in Patients Undergoing Coronary Artery Bypass Grafting with Cardiopulmonary Bypass
por: Kahli, Abdelkader, et al.
Publicado: (2014)

The role of osteoprotegerin in arthritis
por: Schett, Georg, et al.
Publicado: (2003)

The Multifaceted Interplay between Atrial Fibrillation and Myocardial Infarction: A Review
por: Belkouche, Alban, et al.
Publicado: (2021)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Growth Differentiation Factor-15 (GDF-15) Is Associated With Mortality in Ischemic Stroke Patients Treated With Acute Revascularization Therapy
por: Brenière, Céline, et al.
Publicado: (2019)

The Ligand for Osteoprotegerin (OPGL) Directly Activates Mature Osteoclasts
por: Burgess, Teresa L., et al.
Publicado: (1999)

Osteoprotegerin/receptor activator of nuclear factor-κB ligand are involved in periodontitis-promoted vascular calcification
por: Jiao, Mengyu, et al.
Publicado: (2022)

Therapeutic implications of osteoprotegerin
por: Fili, Sofia, et al.
Publicado: (2009)

Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis.
por: Park, Hye-Rim, et al.
Publicado: (2003)

Osteoprotegerin in Cardiometabolic Disorders
por: Pérez de Ciriza, C., et al.
Publicado: (2015)

Role of RANKL–RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications
por: Kohli, Sarvraj Singh, et al.
Publicado: (2011)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
por: Trouvin, Anne-Priscille, et al.
Publicado: (2010)

Is There a Correlation between Vitamin C Status and Catecholamines Concentrations in Hemodialysis Patients?
por: Coquet, Isaline, et al.
Publicado: (2008)

Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients
por: El Baz, Tarek Z., et al.
Publicado: (2017)

Serum Osteoprotegerin Levels and the Vascular Reactivity Index in Patients with Hypertension
por: Chen, Yen-Liang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hmg6ofqmd5kvira7fdsau3md3b